Literature DB >> 24900535

Hepatitis C virus protease inhibitors: patent highlight.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2012        PMID: 24900535      PMCID: PMC4025661          DOI: 10.1021/ml300199d

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

Review 1.  Resistance to anti-HCV protease inhibitors.

Authors:  Alexander J Thompson; Stephen A Locarnini; Michael R Beard
Journal:  Curr Opin Virol       Date:  2011-10-28       Impact factor: 7.090

Review 2.  Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C.

Authors:  Bryce S Foote; Linda M Spooner; Paul P Belliveau
Journal:  Ann Pharmacother       Date:  2011-08-09       Impact factor: 3.154

  2 in total
  1 in total

1.  Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors.

Authors:  Lavanya Bondada; Ramu Rondla; Ugo Pradere; Peng Liu; Chengwei Li; Drew Bobeck; Tamara McBrayer; Philip Tharnish; Jerome Courcambeck; Philippe Halfon; Tony Whitaker; Franck Amblard; Steven J Coats; Raymond F Schinazi
Journal:  Bioorg Med Chem Lett       Date:  2013-09-30       Impact factor: 2.823

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.